Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
暂无分享,去创建一个
S. Yerly | S. Tan | S. Murad | Vishal Goyal | A. Avihingsanon | W. Chan | T. Cressey | F. Simon | H. Tee | B. Pécoul | M. Hassan | I. Andrieux-Meyer | Satawat Thongsawat | Nicolas Salvadori | N. Ngo-Giang-Huong | F. Bompart | S. Thanprasertsuk | S. Khemnark | H. Omar | S. Siva | Suresh Kumar | Caroline Menétrey | H. Said | K. Thetket | Alistair Swanson